Investing.com - Celularity reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Celularity announced earnings per share of $0.03 on revenue of $4.14M. Analysts polled by Investing.com anticipated EPS of $-0.26 on revenue of $6.18M.
Celularity shares are down 53.92% from the beginning of the year, still down 83.85% from its 52 week high of $13.19 set on April 28.
Celularity follows other major Healthcare sector earnings this month
Celularity's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar